Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Fluids and Barriers of the CNS
|
June 27, 2022
Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus
Eva Kjer Oernbo, Annette Buur Steffensen, Hanne Gredal, et al.
Neuroimage. Clinical
|
May 18, 2020
Evaluating 2-[<sup>18</sup>F]FDG-PET in differential diagnosis of dementia using a data-driven decision model
Le Gjerum, Kristian Steen Frederiksen, Otto Mølby Henriksen, et al.
Interface Focus
|
January 16, 2014
The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease
Kari Antila, Jyrki Lötjönen, Lennart Thurfjell, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 23, 2023
Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by <i>CHMP2B</i> mutation
Anders Toft, Simon Sjödin, Anja Hviid Simonsen, et al.
Neuroepidemiology
|
October 19, 2013
Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design
Kristine Hoffmann, Kristian S Frederiksen, Nanna Aue Sobol, et al.
Journal of the Neurological Sciences
|
June 13, 2026
Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort
Daniel Kjaergaard, T Rune Nielsen, Erik Stomrud, et al.
Fluids and Barriers of the CNS
|
January 20, 2023
Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
Nina Rostgaard, Markus Harboe Olsen, Maud Ottenheijm, et al.
Journal of Neuroimmunology
|
September 9, 2018
Inflammatory markers of CHMP2B-mediated frontotemporal dementia
Peter Roos, Marina Rode von Essen, Troels Tolstrup Nielsen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 18, 2026
Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition
Marc Clos-Garcia, Asger Wretlind, Tik Muk, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 24, 2019
Patients with Alzheimer's disease who carry the <i>APOE</i> ε4 allele benefit more from physical exercise
Camilla Steen Jensen, Anja Hviid Simonsen, Volkert Siersma, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Fluids and Barriers of the CNS
|
June 27, 2022
Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus
Eva Kjer Oernbo, Annette Buur Steffensen, Hanne Gredal, et al.
Neuroimage. Clinical
|
May 18, 2020
Evaluating 2-[<sup>18</sup>F]FDG-PET in differential diagnosis of dementia using a data-driven decision model
Le Gjerum, Kristian Steen Frederiksen, Otto Mølby Henriksen, et al.
Interface Focus
|
January 16, 2014
The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease
Kari Antila, Jyrki Lötjönen, Lennart Thurfjell, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 23, 2023
Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by <i>CHMP2B</i> mutation
Anders Toft, Simon Sjödin, Anja Hviid Simonsen, et al.
Neuroepidemiology
|
October 19, 2013
Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design
Kristine Hoffmann, Kristian S Frederiksen, Nanna Aue Sobol, et al.
Journal of the Neurological Sciences
|
June 13, 2026
Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort
Daniel Kjaergaard, T Rune Nielsen, Erik Stomrud, et al.
Fluids and Barriers of the CNS
|
January 20, 2023
Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
Nina Rostgaard, Markus Harboe Olsen, Maud Ottenheijm, et al.
Journal of Neuroimmunology
|
September 9, 2018
Inflammatory markers of CHMP2B-mediated frontotemporal dementia
Peter Roos, Marina Rode von Essen, Troels Tolstrup Nielsen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 18, 2026
Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition
Marc Clos-Garcia, Asger Wretlind, Tik Muk, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 24, 2019
Patients with Alzheimer's disease who carry the <i>APOE</i> ε4 allele benefit more from physical exercise
Camilla Steen Jensen, Anja Hviid Simonsen, Volkert Siersma, et al.
Page
of 10